Drugs that contain Esmolol Hydrochloride
1. Brevibloc patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(2 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(2 years ago) | |
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE;INJECTION
How can I launch a generic of BREVIBLOC before it's drug patent expiration?
More Information on Dosage
BREVIBLOC family patents
2. Brevibloc Double Strength In Plastic Container patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(2 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(2 years ago) | |
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE;INJECTION
How can I launch a generic of BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER before it's drug patent expiration?
More Information on Dosage
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER family patents
3. Brevibloc In Plastic Container patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(2 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(2 years ago) | |
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE;INJECTION
How can I launch a generic of BREVIBLOC IN PLASTIC CONTAINER before it's drug patent expiration?
More Information on Dosage
BREVIBLOC IN PLASTIC CONTAINER family patents
4. Esmolol Hydrochloride Double Strength In Plastic Container patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6528540 | HQ SPCLT PHARMA | Esmolol formulation |
Jan, 2021
(3 years ago) | |
| US6310094 | HQ SPCLT PHARMA | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
|
US6528540 (Pediatric) | HQ SPCLT PHARMA | Esmolol formulation |
Jul, 2021
(2 years ago) | |
|
US6310094 (Pediatric) | HQ SPCLT PHARMA | Ready-to-use esmolol solution |
Jul, 2021
(2 years ago) | |
| US8835505 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(8 years from now) | |
| US8829054 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(8 years from now) | |
Market Authorisation Date: 07 April, 2016
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER family patents
5. Esmolol Hydrochloride In Plastic Container patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6528540 | HQ SPCLT PHARMA | Esmolol formulation |
Jan, 2021
(3 years ago) | |
| US6310094 | HQ SPCLT PHARMA | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | HQ SPCLT PHARMA | Ready-to-use esmolol solution |
Jul, 2021
(2 years ago) | |
|
US6528540 (Pediatric) | HQ SPCLT PHARMA | Esmolol formulation |
Jul, 2021
(2 years ago) | |
| US8835505 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(8 years from now) | |
| US8829054 | HQ SPCLT PHARMA | Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container |
Mar, 2033
(8 years from now) | |
Market Authorisation Date: 07 April, 2016
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER family patents